Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study

Carmen Concerto, Giuseppe Lanza, Mariagiovanna Cantone, Raffaele Ferri, Giovanni Pennisi, Rita Bella, Eugenio Aguglia

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: In this study we aimed to assess the long-term efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) on depressive symptoms and cognitive performance in patients with drug-resistant major depressive disorder (MDD).

METHODS: Fifteen drug-resistant depressed outpatients completed an acute trial with augmentative high-frequency rTMS over the left dorsolateral prefrontal cortex (DLPFC) and were compared with 15 drug-resistant MDD patients who underwent sham procedure. Depressive symptoms were evaluated with the Hamilton Depression Rating Scale and Montgomery-Asberg Depression Rating Scale. The Frontal Assessment Battery and the Stroop Color-Word Test Interference (Stroop T) were used to probe executive functions. Outcome measures were obtained at baseline, 4 weeks after the rTMS, as well as 3 months and 6 months after the end of the stimulation protocol.

RESULTS: After the active rTMS, patients showed a significant decrease in the scores at the depression rating scales that lasted for 6 months. A transient improvement was also observed at the Stroop T, although it did not persist in time.

CONCLUSIONS: High-frequency rTMS over the left DLPFC may have long-term antidepressant effect in drug-resistant MDD. TMS is a valuable tool for the add-on treatment of mood disorders and for the design of customized stimulation protocols.

Original languageEnglish
Pages (from-to)252-258
Number of pages7
JournalInternational Journal of Psychiatry in Clinical Practice
Volume19
Issue number4
DOIs
Publication statusPublished - 2015

Fingerprint

Transcranial Magnetic Stimulation
Depression
Major Depressive Disorder
Pharmaceutical Preparations
Prefrontal Cortex
Stroop Test
Executive Function
Mood Disorders
Antidepressive Agents
Outpatients
Color
Outcome Assessment (Health Care)

Keywords

  • Cortical excitability
  • drug-resistant major depression
  • neural plasticity
  • repetitive TMS

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression : A six-month clinical follow-up study. / Concerto, Carmen; Lanza, Giuseppe; Cantone, Mariagiovanna; Ferri, Raffaele; Pennisi, Giovanni; Bella, Rita; Aguglia, Eugenio.

In: International Journal of Psychiatry in Clinical Practice, Vol. 19, No. 4, 2015, p. 252-258.

Research output: Contribution to journalArticle

Concerto, Carmen ; Lanza, Giuseppe ; Cantone, Mariagiovanna ; Ferri, Raffaele ; Pennisi, Giovanni ; Bella, Rita ; Aguglia, Eugenio. / Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression : A six-month clinical follow-up study. In: International Journal of Psychiatry in Clinical Practice. 2015 ; Vol. 19, No. 4. pp. 252-258.
@article{c0f436fa4bba4662981b72436c0ac8d4,
title = "Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study",
abstract = "OBJECTIVE: In this study we aimed to assess the long-term efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) on depressive symptoms and cognitive performance in patients with drug-resistant major depressive disorder (MDD).METHODS: Fifteen drug-resistant depressed outpatients completed an acute trial with augmentative high-frequency rTMS over the left dorsolateral prefrontal cortex (DLPFC) and were compared with 15 drug-resistant MDD patients who underwent sham procedure. Depressive symptoms were evaluated with the Hamilton Depression Rating Scale and Montgomery-Asberg Depression Rating Scale. The Frontal Assessment Battery and the Stroop Color-Word Test Interference (Stroop T) were used to probe executive functions. Outcome measures were obtained at baseline, 4 weeks after the rTMS, as well as 3 months and 6 months after the end of the stimulation protocol.RESULTS: After the active rTMS, patients showed a significant decrease in the scores at the depression rating scales that lasted for 6 months. A transient improvement was also observed at the Stroop T, although it did not persist in time.CONCLUSIONS: High-frequency rTMS over the left DLPFC may have long-term antidepressant effect in drug-resistant MDD. TMS is a valuable tool for the add-on treatment of mood disorders and for the design of customized stimulation protocols.",
keywords = "Cortical excitability, drug-resistant major depression, neural plasticity, repetitive TMS",
author = "Carmen Concerto and Giuseppe Lanza and Mariagiovanna Cantone and Raffaele Ferri and Giovanni Pennisi and Rita Bella and Eugenio Aguglia",
year = "2015",
doi = "10.3109/13651501.2015.1084329",
language = "English",
volume = "19",
pages = "252--258",
journal = "International Journal of Psychiatry in Clinical Practice",
issn = "1365-1501",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression

T2 - A six-month clinical follow-up study

AU - Concerto, Carmen

AU - Lanza, Giuseppe

AU - Cantone, Mariagiovanna

AU - Ferri, Raffaele

AU - Pennisi, Giovanni

AU - Bella, Rita

AU - Aguglia, Eugenio

PY - 2015

Y1 - 2015

N2 - OBJECTIVE: In this study we aimed to assess the long-term efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) on depressive symptoms and cognitive performance in patients with drug-resistant major depressive disorder (MDD).METHODS: Fifteen drug-resistant depressed outpatients completed an acute trial with augmentative high-frequency rTMS over the left dorsolateral prefrontal cortex (DLPFC) and were compared with 15 drug-resistant MDD patients who underwent sham procedure. Depressive symptoms were evaluated with the Hamilton Depression Rating Scale and Montgomery-Asberg Depression Rating Scale. The Frontal Assessment Battery and the Stroop Color-Word Test Interference (Stroop T) were used to probe executive functions. Outcome measures were obtained at baseline, 4 weeks after the rTMS, as well as 3 months and 6 months after the end of the stimulation protocol.RESULTS: After the active rTMS, patients showed a significant decrease in the scores at the depression rating scales that lasted for 6 months. A transient improvement was also observed at the Stroop T, although it did not persist in time.CONCLUSIONS: High-frequency rTMS over the left DLPFC may have long-term antidepressant effect in drug-resistant MDD. TMS is a valuable tool for the add-on treatment of mood disorders and for the design of customized stimulation protocols.

AB - OBJECTIVE: In this study we aimed to assess the long-term efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) on depressive symptoms and cognitive performance in patients with drug-resistant major depressive disorder (MDD).METHODS: Fifteen drug-resistant depressed outpatients completed an acute trial with augmentative high-frequency rTMS over the left dorsolateral prefrontal cortex (DLPFC) and were compared with 15 drug-resistant MDD patients who underwent sham procedure. Depressive symptoms were evaluated with the Hamilton Depression Rating Scale and Montgomery-Asberg Depression Rating Scale. The Frontal Assessment Battery and the Stroop Color-Word Test Interference (Stroop T) were used to probe executive functions. Outcome measures were obtained at baseline, 4 weeks after the rTMS, as well as 3 months and 6 months after the end of the stimulation protocol.RESULTS: After the active rTMS, patients showed a significant decrease in the scores at the depression rating scales that lasted for 6 months. A transient improvement was also observed at the Stroop T, although it did not persist in time.CONCLUSIONS: High-frequency rTMS over the left DLPFC may have long-term antidepressant effect in drug-resistant MDD. TMS is a valuable tool for the add-on treatment of mood disorders and for the design of customized stimulation protocols.

KW - Cortical excitability

KW - drug-resistant major depression

KW - neural plasticity

KW - repetitive TMS

UR - http://www.scopus.com/inward/record.url?scp=84986588450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986588450&partnerID=8YFLogxK

U2 - 10.3109/13651501.2015.1084329

DO - 10.3109/13651501.2015.1084329

M3 - Article

C2 - 26398527

AN - SCOPUS:84947129331

VL - 19

SP - 252

EP - 258

JO - International Journal of Psychiatry in Clinical Practice

JF - International Journal of Psychiatry in Clinical Practice

SN - 1365-1501

IS - 4

ER -